| Literature DB >> 35505310 |
Theodora Monica Carissa1, Ezzah Fatmala Daulay1, Dicky Yulianda1, Kristy Iskandar2, Andi Dwihantoro1.
Abstract
BACKGROUND: Hirschsprung disease (HSCR) is a common congenital disorder presenting with functional obstruction due to aganglionosis of the colon. There are numerous types of pull-through surgery for managing HSCR, such as transabdominal endorectal (Soave), Swenson, Duhamel, transanal endorectal pull-through (TEPT), and laparoscopic (Georgeson) approach. Here, we aimed to describe the long-term outcome of patients with HSCR who underwent transabdominal Soave, Duhamel, and TEPT in our institution.Entities:
Keywords: Bowel function score; Definitive surgery; Hirschsprung disease; Long-term functional outcome; Transabdominal- and transanal pull-through
Mesh:
Year: 2022 PMID: 35505310 PMCID: PMC9063042 DOI: 10.1186/s12887-022-03301-6
Source DB: PubMed Journal: BMC Pediatr ISSN: 1471-2431 Impact factor: 2.567
Fig. 1Flowchart of study inclusion and exclusion criteria
Baseline characteristics of HSCR patients who underwent pull-through in this study
| Characteristics | Soave ( | TEPT ( | Duhamel ( |
|---|---|---|---|
| Sex (n, %) | |||
| ▪ Male | 8 (100) | 7 (53.8) | 3 (75) |
| ▪ Female | 0 | 6 (46.2) | 1 (25) |
| Aganglionosis type (n, %) | |||
| ▪ Short | 8 (100) | 12 (92.3) | 4 (100) |
| ▪ Long | 0 | 1 (7.7) | 0 |
| Age at HSCR diagnosis (median, IQR) (months) | 9.5 (2.75–26.5) | 6 (1–32) | 25.5 (12–39) |
| Age at definitive surgery (median, IQR) (months) | 18.5 (13.25–35) | 6 (1–37) | 43 (29.5–54.75) |
| Length of follow-up (median, IQR) (months) | 80 (59–93) | 55 (42–78) | 99.5 (88–100) |
HSCR Hirschsprung disease, IQR interquartile range, TEPT transanal endorectal pull-through
BFS in HSCR patients after pull-through procedure
| BFS | Pull-through | Total | |||
|---|---|---|---|---|---|
| Poor | 2 (50) | 1 (12.5) | 0 | 0.027* | 3 (12) |
| Fair | 1 (25) | 0 | 0 | 1 (4) | |
| Good | 1 (25) | 4 (50) | 6 (46) | 11 (44) | |
| Normal | 0 | 3 (37.5) | 7 (54) | 10 (40) | |
*significant (p < 0.05), BFS bowel function score, HSCR Hirschsprung disease
Analysis of BFS components for each pull-through performed
| BFS | Pull-through | |||
|---|---|---|---|---|
| Duhamel (n, %) | Soave (n, %) | TEPT (n, %) | ||
| Ability to hold back defecation | ||||
| ▪ No voluntary control | 1 (25) | 3 (37.5) | 1 (7.7) | 0.383 |
| ▪ Weekly problems | 1 (25) | 0 | 2 (15.4) | |
| ▪ Problems less than 1/week | 1 (25) | 0 | 2 (15.4) | |
| ▪ Always | 1 (25) | 5 (62.5) | 8 (61.5) | |
| Feels/reports the urge to defecate | ||||
| ▪ Absent | 1 (25) | 1 (12.5) | 0 | 0.542 |
| ▪ Uncertain | 1 (25) | 1 (12.5) | 1 (7.7) | |
| ▪ Most of the time | 1 (25) | 1 (12.5) | 2 (15.3) | |
| ▪ Always | 1 (25) | 5 (62.5) | 10 (77) | |
| Frequency of defecation | ||||
| ▪ More often/less often | 2 (50) | 3 (37.5) | 2 (15.4) | 0.310 |
| ▪ Every other day to twice a day | 2 (50) | 5 (62.5) | 11 (84.6) | |
| Soiling | ||||
| ▪ Daily soiling, requires protective aids | 2 (50) | 0 | 0 | 0.030* |
| ▪ Frequent staining, change of underwear often required | 1 (25) | 3 (37.5) | 1 (23) | |
| ▪ Staining less than 1/week, no change of underwear required | 1 (25) | 1 (12.5) | 5 (38.5) | |
| ▪ Never | 0 | 4 (50) | 5 (38.5) | |
| Accidents | ||||
| ▪ Daily, require protective aids during day and night | 3 (75) | 2 (25) | 1 (7.7) | 0.035* |
| ▪ Weekly accidents; often require protective aids | 0 | 0 | 1 (23) | |
| ▪ Fewer than 1/week | 1 (25) | 0 | 2 (23) | |
| ▪ Never | 0 | 6 (75) | 6 (46.2) | |
| Constipation | ||||
| ▪ Manageable with enemas | 0 | 0 | 0 | 0.181 |
| ▪ Manageable with laxative | 1 (25) | 2 (25) | 0 | |
| ▪ Manageable with diet | 0 | 1 (12.5) | 0 | |
| ▪ No constipation | 3 (75) | 5 (62.5) | 13 (100) | |
| Social problems | ||||
| ▪ Several social and/or psychic problem | 0 | 0 | 0 | 0.647 |
| ▪ Problems causing restrictions in social life | 0 | 0 | 0 | |
| ▪ Sometimes (foul odors) | 1 (25) | 1 (12.5) | 1 (7.7) | |
| ▪ No social problems | 3 (75) | 7 (78.5) | 12 (92.3) | |
*significant (p < 0.05), BFS bowel function score, HSCR Hirschsprung disease